NovoCure Balance Sheet
NovoCure's total assets for Q4 2025 were $804.33M, a decrease of -40.91% from the previous quarter. NVCR total liabilities were $463.86M for the fiscal quarter, a -54.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.